جست‌وجوی استاد و پژوهشگر

Eric W. Kleeمشاهده پروفایل

استاد

• Omics Data Analysis
• Rare and Undiagnosed Diseases
• Genomic Medicine
• +۳ مورد دیگر

Eric W. Klee, Ph.D., is a Professor of Biomedical Informatics at Mayo Clinic, leading translational research in omics data integration and precision medicine. He holds key roles including Scientific Director of Research Data and Digital Innovation, Enterprise Co-Leader of Cancer Informatics & Data Science at the Mayo Clinic Comprehensive Cancer Center, and Director of Digital Omics in the Center for Individualized Medicine. His work focuses on rare disease diagnosis, genomic data infrastructure, and machine learning applications in healthcare. Education: Ph.D. in Health Informatics, University of Minnesota MS in Health Informatics, University of Minnesota BS in Electrical Engineering, Iowa State University Research Interests: Dr. Klee’s research integrates multi-omics profiling, AI-driven analytics, and cloud-based platforms to advance diagnostics and treatment for rare genetic disorders. He leads initiatives like RADIaNT (RNA sequencing for rare diseases), SAVI (automated variant interpretation), and RENEW (continuous genomic data reanalysis). His work bridges lab discoveries with clinical practice, emphasizing precision medicine and scalable genomic solutions. Publications Trends: His recent work highlights RNA-based diagnostics, AI in variant prioritization, and infrastructure for population-level genomic screening. Key areas include drug repositioning for tobacco dependence and molecular mechanisms of Mendelian diseases. Awards: Research Award from the Minnesota Partnership for Biotechnology and Medical Genomics (2023) Advising & Grants: Leads the Mayo Clinic’s Digital Omics initiative and co-leads cancer informatics efforts. His lab collaborates on NIH-funded studies and industry partnerships to translate genomic insights into clinical tools. Labs/Teams: Directs the Advanced Diagnostics Laboratory’s bioinformatics team and chairs the Undiagnosed Diseases Network International board, fostering global rare disease research collaboration.

Lorenzo Farinaمشاهده پروفایل

استاد

• Network Medicine
• Bioinformatics
• Systems Biology
• +۶ مورد دیگر

Lorenzo Farina is a Full Professor at Sapienza University of Rome's Faculty of Information Engineering, Computer Science and Statistics, specializing in Electronic and Computer Bioengineering (ING-INF/06). With over 25 years of academic leadership, he co-founded Italy's first Bioinformatics degree program and established key oncology precision medicine initiatives, maintaining active collaborations with Harvard Medical School's network medicine division. His educational background includes a cum laude Electronic Engineering degree and PhD in Systems Engineering, both from Sapienza University. These foundational studies evolved into pioneering work in positive linear systems theory, evidenced by his highly-cited Wiley textbook Positive Linear Systems: Theory and Applications (2000). Farina's research centers on network medicine – applying complex network science to molecular medicine since his 2004 breakthrough. His work spans cancer mechanisms (breast, glioblastoma, lung), drug repositioning (including COVID-19 applications), and liquid biopsy biomarker development. Current projects focus on miRNA-based network biomarkers for cancer diagnostics and immunotherapy response prediction, integrating multi-omics data through advanced computational frameworks. Analysis of his 15 most recent publications (2024-2025) reveals dominant themes: sexual dimorphism in cancer networks (MIRROR platform), immunotherapy response signatures, and critical examinations of AI's role in precision medicine. His work consistently bridges computational innovation with clinical applications, particularly in oncology diagnostics and therapeutic optimization. His scientific recognition includes: 2001 Guillemin-Cauer Award for best IEEE Transactions on Circuits and Systems article 2014 SysBio Award for annual best publication Farina actively mentors through interdisciplinary programs he established, including the Network Oncology doctoral program. His laboratory collaborations span Sapienza's Oncogenomics and Immunology Laboratories, Harvard's Channing Division of Network Medicine, and clinical departments in oncology and radiology, driving translational research from computational models to patient applications. He leads multiple research teams focused on network-based diagnostics, including the MIRROR platform for cancer disparity analysis and liquid biopsy development teams investigating circulating miRNA networks for early cancer detection across multiple malignancies.

Michael Baudisمشاهده پروفایل

استاد

• Bioinformatics
• Tumorgenomics
• Genomics
• +۴ مورد دیگر

Michael Baudis is a Professor of Bioinformatics and Tumorgenomics at the Institute of Molecular Biology , Faculty of Science, University of Zurich. He leads the development of the Progenetix database, a global reference for cancer genomic copy number alterations, and contributes to international standards through his membership in the Global Alliance for Genomics and Health (GA4GH) . Research focuses on genomic data representation , cancer subtype classification , and data sharing protocols Key projects include Beacon networks , Phenopackets , and GA4GH standards Email: michael.baudis@uzh.ch His recent work explores short tandem repeat variations , attention-based deep learning for CNAs , and heterogeneity in cancer classifications . Methodological contributions include segment_liftover , CNARA , and pgxRpi for genomic data calibration and analysis.

Sara E. Wobkerمشاهده پروفایل

دانشیار

• Genitourinary Pathology
• Molecular Characterization of Cancers
• Bladder Cancer Research
• +۳ مورد دیگر

Sara E. Wobker, MD, MPH, is an Associate Professor in both the Department of Pathology and Laboratory Medicine and the Department of Urology at the University of North Carolina at Chapel Hill . She also serves as Director of Anatomic Pathology , Director of Genitourinary Pathology , and Director of Surgical Pathology . Her research focuses on genitourinary malignancies , particularly the molecular characterization of rare variants of bladder carcinoma . She aims to translate histologic findings into molecular discoveries to improve patient care, with a recent emphasis on tumor microenvironment dynamics and immunotherapy response mechanisms in muscle-invasive bladder cancer. Analysis of her 15 most recent articles (2024-2021) reveals a strong trend in immunotherapy response , molecular subtyping , and diagnostic standardization for genitourinary cancers. Key subfields include FGFR inhibition , TFE3 gene fusions , clinicogenomic features , and pathology protocol optimization . Scientific Awards UNC Junior Faculty Development Award (2018-2019) As Faculty Director of the Pathology Services Core, she supports clinical trials , translational studies , and basic science research . She collaborates extensively with interdisciplinary teams in the UNC Lineberger Comprehensive Cancer Center, contributing to updates in renal and prostate cancer grading through the Genitourinary Pathology Society (GUPS).

• Genomics
• Bioinformatics
• Molecular Biology
• +۷ مورد دیگر

Martin Smith is an Assistant Professor at the Université de Montréal in the Department of Biochemistry and Molecular Medicine . His research focuses on harmonizing genomic technologies and artificial intelligence for precision medicine and functional genome annotation , particularly using single-molecule sequencing and computational biology approaches. PhD in Genomics from University of Queensland (2012) Postdoctoral work at Garvan Institute of Medical Research Director of Genomic Technologies Program at Kinghorn Centre for Clinical Genomics (2017) His research initiatives include transcriptomic profiling using real-time nanopore sequencing , with projects funded by the NSERC , FRQS , Génome Québec , and the Cole Foundation . He supervises M.Sc. student Kristina Atanasova and collaborates with interdisciplinary teams in pediatric acute leukemia and COVID-19 research. Research Highlights : Clonal and transcriptional landscape of lymphocytes Real-time classification of leukemias Evolutionary RNA structure analysis AI-enhanced immunopeptidomics High-resolution RNA sequencing methods Scientific Awards : CSIRO Pre-Incubator Performance Award Palmer Foundation Innovation Award Megabase DNA Sequencing Prize Robert Cedergren Bioinformatics Poster Prize Martin Smith is recognized for developing bioinformatics tools like DotAligner and SLOW5 , and will direct the Ramaciotti Centre for Genomics at UNSW Sydney starting 2024. His work bridges biotechnology and high-performance computing to advance precision medicine applications for conditions including Leishmania and acute leukemia .

Steven J Jonesمشاهده پروفایل

استاد

• Bioinformatics
• Gene Expression
• Gene Regulation
• +۷ مورد دیگر

Dr. Steven J. Jones is a Professor in the Department of Medical Genetics at the University of British Columbia (UBC) and Associate Director/Head of Bioinformatics at the Genome Sciences Centre, BC Cancer Research Centre. He serves as Director of the CIHR/MSFHR Bioinformatics Training Program and the UBC Bioinformatics Graduate Program, with associate memberships at the Peter Wall Institute for Advanced Studies and Michael Smith Laboratories. Dr. Jones' research focuses on computational genomics and cancer bioinformatics , analyzing mutational landscapes and epigenetic targets in oncology. His work includes next-generation sequencing , structural variant detection , and long-read sequencing applications for resolving complex genomic architectures. He has extensive experience with transcriptome analysis , gene regulation , and comparative genomics across diverse organisms including C. elegans , conifers, and human pathogens. His 15 most recent publications highlight expertise in long-read sequencing for cancer genomics , imprinting disorders , and structural variation analysis. Key contributions include developing the Circos visualization tool for comparative genomics and pioneering bioinformatics approaches for epigenetic modifier discovery in oncology. Scientific Awards : Spencer Award for IT innovation (2005) 2007 Medical Genetics teaching award (UBC) 2011 Fellow of the Royal Society of Canada 2012 UBC Killam teaching prize 2014 Distinguished Achievement Award (UBC Faculty of Medicine) 2014 Fellow of the Canadian Academy of Health Sciences Clarivate Analytics Highly Cited Researcher (2016, 2018) Dr. Jones actively advises graduate students and serves as a data analysis center for the Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC). He co-founded Ifowonco Bioinformatics Inc. and Alamya Health, PBC, and consults for Apotheca Systems Inc.

William S. Bushمشاهده پروفایل

استاد

• Bioinformatics
• Genomics
• Genetic Epidemiology
• +۴ مورد دیگر

William S. Bush, PhD, is Professor in the Department of Population and Quantitative Health Sciences and Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine, serving as Associate Director for Computational Genomics at the Institute for Computational Biology. His research integrates functional genomics knowledge into genetic analysis and leverages electronic medical records for translational applications in neurocognitive disorders. Education: PhD, Vanderbilt University, 2008 MS, Vanderbilt University, 2008 Dr. Bush specializes in bioinformatics and statistical methods development for detecting complex genetic effects, knowledge-guided genomic analysis using structured biological hypotheses, and genetic epidemiology of Alzheimer's Disease and HIV-associated neurocognitive disorders. His work emphasizes nuclear and mitochondrial genetic interactions and pathway-based analytical approaches. His 2019-2020 publications reveal strong focus on Alzheimer's disease genomics through large consortia like the Alzheimer's Disease Sequencing Project, with significant contributions to software engineering for reproducible bioinformatics, pathway analysis methodologies, and multi-ethnic genomic studies. Key themes include immune pathway involvement in neurodegeneration and translational applications of genomic data. Scientific Awards: None listed in source materials. Dr. Bush mentors Master's students, PhD candidates, and postdoctoral fellows while leading major NIH-funded initiatives: NIH/NIA RO1: Genetic drivers of resilience to Alzheimer’s disease NIH/NIGMS RO1: Atlas of clinical associations mapping to protein structures NIH/NIA UO1: Alzheimer’s Disease sequence analysis collaborative USDA/Foundation for Food and Agriculture Research: Modeling neighborhood food futures NIH/NIDDK U2: Cleveland KPMP recruitment network NIH/NIAID R56: Genetics of TB resistance in HIV+ subjects NIH/NIA U54: Alzheimer’s Disease Sequencing Project coordination NIH/NIA U01: Replication of ADSP discoveries in African-Americans NIH/NIA R01: Genetics of Alzheimer Disease in Puerto Ricans He co-chairs the ADSP Annotation Working Group, develops widely used genomic annotation resources, and holds external appointments at Cleveland Clinic Genomic Medicine Institute and Cleveland Institute for Computational Biology.

Jing Yangمشاهده پروفایل

استادیار

• Biostatistics
• Computational Biology
• Genomics
• +۶ مورد دیگر

Jing Yang is an Assistant Professor of Biostatistics at Vanderbilt University Medical Center. With a PhD in Molecular Biology and Biochemistry from East China University of Science and Technology & Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences, Yang specializes in computational genomics, immunogenomics, and pharmacogenetics. Education: PhD in Molecular Biology and Biochemistry Research interests include: Genomic determinants of immunotherapy response Pharmacogenetic mechanisms in infectious diseases Dysfunctional regulatory networks in cancer and autoimmune diseases Development of bioinformatics tools for disease similarity and gene coexpression analysis Recent publications span topics such as tumor-immune feedback loops, pharmacogenomics of tuberculosis treatment, and computational modeling of disease networks. Yang's work integrates biostatistical methods with multi-omics data to address complex biological questions. Email: jing.yang@vumc.org

• Bioinformatics
• Computational Biology
• Pharmacogenomics
• +۵ مورد دیگر

Giuseppe Agapito is a Professor at the Department of Law, Economics and Sociology (DiGES) at the University of Camerino, where he teaches courses such as Elements of Computer Science and Data Analysis. He specializes in computational biology, bioinformatics, and health informatics, focusing on genomic data analysis, machine learning applications in healthcare, and parallel computing methodologies. His research integrates multi-omics approaches, pathway enrichment analysis, and predictive modeling for drug response and disease mechanisms. Notable contributions include tools like BioPAX-Parser and cPEA, which enhance genomic data interpretation. He actively collaborates in international studies, such as the 4CE consortium analyzing SARS-CoV-2 impacts. His work addresses challenges in privacy-aware bioinformatics, high-performance computing for genomics, and AI-driven medical diagnostics. Education details are not explicitly provided in the texts, but his academic profile reflects extensive expertise in interdisciplinary fields bridging computer science and biomedical research. He maintains an active research agenda with over 50 publications since 2018, emphasizing scalable data analysis, drug biomarker discovery, and computational methods for clinical outcomes prediction. His teaching responsibilities include IT management and data analysis modules within social science curricula, reflecting a commitment to digital literacy across disciplines. Research interests span bioinformatics tool development, genomic data preprocessing, and AI applications in healthcare, with a focus on translational research. Recent articles highlight advancements in fMRI classification using graph neural networks, privacy-preserving genomic pipelines, and edge-based deep learning for medical signal analysis. Awards and grants are not explicitly listed, but his sustained contribution to international research consortia underscores his field influence. He advises students and researchers on computational methodologies and hosts weekly office hours for academic consultations.

Stephen Ramseyمشاهده پروفایل

دانشیار

• Computational Systems Biology
• Bioinformatics
• Precision Medicine
• +۶ مورد دیگر

Stephen Ramsey, an Associate Professor at Oregon State University, holds dual appointments in the School of Electrical Engineering and Computer Science (College of Engineering) and the Department of Biomedical Sciences (Carlson College of Veterinary Medicine). With a PhD in Physics from the University of Maryland, his postdoctoral training in computational genomics at the University of Washington, and professional experience at the Institute for Systems Biology and Center for Infectious Disease Research, Ramsey bridges computational methods with biomedical applications. Education : Ph.D., Physics, University of Maryland; M.S., Physics, University of Maryland; Sc.B., Mathematical Physics, Brown University Ramsey specializes in computational systems biology , focusing on bioinformatics , biomedical knowledge graphs , and precision medicine . His research integrates machine learning , gene regulatory network modeling , and multi-omics data analysis to address challenges in rare disease diagnostics , drug monitoring , and inflammatory disease mechanisms . Current work includes AI-driven biomedical translation and electrochemical biosensor development for non-invasive diagnostics . Recent publications highlight knowledge graph applications in translational biomedicine , causal network inference in clinical-environmental data integration , and cross-species cancer transcriptomics . His team develops tools like RTX-KG2 and PloverDB to standardize biomedical data sharing and semantic reasoning . Scientific Awards : 2019 Zoetis Award (Carlson College of Veterinary Medicine) 2016 NSF CAREER Award 2016 PhRMA New Investigator Award 2010 NIH K25 Mentored Quantitative Research Award Ramsey advises in computational biology courses (CS 446/546) and contributes to biomedical AI through projects like mediKanren for rare disease diagnostics . His NSF-funded research explores gene expression noise and regulatory network dynamics , while NIH and PhRMA grants support his translational medicine initiatives. He leads the Ramsey Laboratory , which develops graph-based reasoning tools for biomedical data translation and multi-omics integration . The lab's work spans comparative oncology models, electrochemical biosensors , and knowledge graph infrastructure for clinical decision support .

• Breast Cancer
• Medical Oncology
• Genomics
• +۳ مورد دیگر

Dr. Lajos Pusztai is a Professor of Medicine at Yale University and Scientific Co-Director of the Breast Center at the Yale Cancer Center. He holds leadership roles including Co-Director of the Genetics, Genomics, and Epigenetics Program and chairs the Breast Cancer Research Committee of SWOG. His research focuses on breast cancer subtypes, genomic profiling, and clinical trials for targeted therapies. He has authored over 250 publications, including work in high-impact journals like NEJM and Lancet Oncology. Dr. Pusztai received his MD from Semmelweis University and D.Phil. from Oxford University. Education: Medical Degree: Semmelweis University School of Medicine (1987) D.Phil.: University of Oxford (1993) Residency: University of Rochester St. Mary's Hospital (1996) Fellowship: University of Texas MD Anderson Cancer Center (1999) Research Interests: His work established key distinctions between estrogen receptor-positive and-negative breast cancers, pioneered gene expression profiling for treatment prediction, and developed tools like Residual Cancer Burden (RCB) scoring. He leads clinical trials for immunotherapies and novel drug combinations, emphasizing personalized cancer care. Key Contributions: Clarified clinical value of neoadjuvant chemotherapy in breast cancer subtypes Developed RCB metric for post-therapy assessment Advanced biomarker-driven therapy through genomic studies Awards: Clinical Science Research Prize (2022) Top 1% Highly Cited Investigator (2015) Advising & Grants: Leads multiple clinical trials (e.g., I-SPY2, NA-PHER2) and collaborates with institutions globally. His team includes prominent researchers like David Rimm and Kim Blenman. Grants focus on translational research and clinical trial innovation. Labs & Teams: Pusztai Lab Subset Medical Oncology Group at Yale Cancer Center, focusing on breast cancer genomics and clinical translation.

Jussi Taipaleمشاهده پروفایل

استاد

• Gene regulation
• Transcription factors
• Systems biology
• +۴ مورد دیگر

Jussi Taipale is a Professor of Medical Systems Biology at Karolinska Institutet and holds professorships at University of Helsinki. His research focuses on transcription factor binding mechanisms , cancer genomics , and gene regulatory networks . The interdisciplinary Taipale Lab operates across three international locations: Wellcome Sanger Institute (UK), Karolinska Institutet (Sweden), and University of Helsinki (Finland), with over 20 members including senior scientists, postdoctoral fellows, and graduate students. Ph.D., University of Helsinki (1996) Postdoctoral training: University of Helsinki, Johns Hopkins University Research spans transcription factor cooperativity , epigenetic regulation , chromatin accessibility , and noncoding mutation analysis . Key methodologies include HT-SELEX , CUT&RUN , ATI assays , and CRISPR-based functional genomics . The lab has significantly advanced understanding of Myc-driven oncogenesis , TF-nucleosome interactions , and dinucleotide specificity mechanisms . Notable discoveries include chromatin context-dependent enhancers , water-mediated DNA recognition , and novel composite transcription factor motifs . The group maintains active collaborations across Europe and has trained numerous alumni now leading academic and industry positions worldwide.

• Acute Lymphoblastic Leukemia
• Pediatric Brain Tumors
• Genetic Heterogeneity
• +۵ مورد دیگر

Stephen E. Sallan, MD , is a Professor of Pediatrics at Harvard Medical School and a Physician at Dana-Farber Cancer Institute and Children's Hospital . His career spans over five decades in pediatric hematology/oncology , with a focus on acute lymphoblastic leukemia (ALL) and pediatric brain tumors . Education : MD, Wayne State University School of Medicine (1967) Residencies : Boston Floating Hospital (1968), Children's Hospital of Philadelphia (1969), Hospital for Sick Children, London (1970) Fellowship : Pediatric Oncology, Children's Hospital/DFCI (1972) Leadership Roles : Chief of Staff (1995), Chairman of Medical Staff Executive Committee (1995), Chief of Staff Emeritus (2012) Dr. Sallan's research integrates genetic heterogeneity , disease recurrence , and drug resistance in ALL, with efforts to develop targeted therapies like tumor vaccines and antiangiogenesis agents. His work addresses long-term treatment toxicities (cardiac, skeletal, neurocognitive), particularly in survivors of childhood cancers. His 15 most recent publications (2024–2018) demonstrate ongoing engagement with pharmacogenomics, thrombosis risk models, dietary interventions, and molecular markers in brain tumors. Key subfields include TRK-C in medulloblastoma , asparaginase complications , and DFCI ALL Consortium Protocols . Scientific Awards : Distinguished Alumni Award, Wayne State University School of Medicine (1997) James Carreras Prize for International Pediatrician of the Year (1987) As a leader in pediatric leukemia research , Dr. Sallan has shaped treatment protocols that minimize late effects while improving survival. He collaborates with multidisciplinary teams in neuro-oncology and pharmacogenomics, maintaining active roles in clinical trials and laboratory investigations.

Noam Auslanderمشاهده پروفایل

استادیار

• Machine Learning
• Cancer Genomics
• Tumor Microbiome
• +۴ مورد دیگر

Noam Auslander, Ph.D. is an Assistant Professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute's Ellen and Ronald Caplan Cancer Center. She joined The Wistar Institute in 2021 after completing postdoctoral training at the National Center of Biotechnology Information (NCBI). Dr. Auslander holds a B.S. in computer science and biology from Tel Aviv University and earned her Ph.D. in computer science from the University of Maryland with a combined fellowship at the National Cancer Institute. Dr. Auslander's research focuses on developing advanced machine and deep learning methods to identify factors that drive cancer development and predict patient prognoses. Her work specifically targets the development of deep learning methods to identify new infectious agents in cancer and biologically interpretable machine learning strategies that improve outcome prediction. Her laboratory has several key research directions: Characterization of the Tumor Microbiome with Machine Learning, Quantification of Gut Microbial Genes and Development of Fecal Biomarkers, New Virus Characterization and Detection of Pathogenic Viral Sequences, and Biologically Informed Classifiers of Cancer Treatment Responses. Her publication record demonstrates a strong trajectory in computational cancer biology, with recent high-impact publications in Nature Communications, Nature Medicine, and other top-tier journals. Her work bridges the gap between complex computational methods and biological insights, with particular emphasis on making machine learning models biologically interpretable for clinical translation. V Foundation Grant for Cancer Research ($600,000) Women Scientists Innovation Award for Cancer Research Dr. Auslander leads a research team including a postdoctoral fellow (Abdurrahman Elbasir), graduate students (Anastasia Lucas, Andrew Patterson, Julia C Malnak), and research staff (McKenna Reale, Bryant Duong). Her lab received significant funding for a project aimed at improving immunotherapy responses in cancer patients by identifying reliable biomarkers that predict patient responses to immunotherapy treatments.

Eamonn Maherمشاهده پروفایل

استاد

• Genetics
• Oncology
• Neoplasm
• +۷ مورد دیگر

Professor Eamonn Maher is the Dean of Aston Medical School at Aston University, within the College of Health and Life Sciences. His primary affiliation is with the School of Life & Health Sciences, where he leads research in genetic oncology and rare diseases. His work focuses on understanding the genetic basis of neoplasms, particularly in syndromes like von Hippel-Lindau disease, Birt-Hogg-Dubé syndrome, and hereditary renal cell carcinoma. He has published extensively on topics including genotype-specific cancer risk profiling, molecular diagnostics, and clinical guideline development. Research Interests: Professor Maher's expertise spans cancer genetics, inherited predispositions to tumors, and the molecular mechanisms of genetic disorders. Key areas include: Neoplastic risk profiling in hereditary syndromes Genomic analysis of renal and endocrine tumors Clinical management of phaeochromocytoma/paraganglioma Imprinting disorders and epigenetic mechanisms Public health implications of rare kidney diseases Recent Work Trends: His 2024–2025 publications emphasize: Advances in whole-genome sequencing for rare tumor diagnosis Systematic reviews of multiple primary renal tumors Guideline development for pediatric phaeochromocytoma/paraganglioma Genomic epidemiology of Birt-Hogg-Dubé syndrome Collaborations: His international collaborations include studies on SDHx-deficient cancers, multi-locus imprinting disturbances, and the UK National Registry of Rare Kidney Diseases (RaDaR). He also contributes to initiatives like the ClinGen VHL Variant Curation Expert Panel and ERN GENTURIS. Grants & Labs: While specific grants are not listed, his leadership in RaDaR and involvement in international registries indicate significant grant-funded research. His lab focuses on translational research bridging genetic discovery and clinical practice.